Remote Neuromodulation
Our Clinical TES systems are approved by the Australian Government's Therapeutic Goods Administration (TGA) ARTG Entry: 284637
Deployed transcranial electrical stimulation, without compromise.
Soterix Medical REMOTE Neuromodulation is the only system with device, accessories, and software designed for deployed use. Safe transcranial Electrical Stimulation requires advanced systems designed for consistency and control. REMOTE Neuromodulation is the only system designed from the ground up to allow translation of clinical tES, including tDCS protocols, to diverse deployed environments, while maintaining medical standards.
Remote Neuromodulation
-
Supervised Remote Neuromodulation
-
Mini-CT
-
Clinical ARTG Entry
-
SNAPstrap/SNAP pads https://soterixmedical.com/research/1x1/accessories/snapstrap
-
ElectraRX https://soterixmedical.com/research/remote/electrarx
-
Locked down/safety remote supervised
-
Data regulations, compliance Australian Privacy Acthttps://www.brainstimjrnl.com/article/S1935-861X(20)30033-4/pdf
mini-CT device
Fail-safe and intelligent hand-held stimulators designed specifically for deployed use. Deliver only the right dose at the right time, with onboard compliance recording and ElectraRx compatibility.
.png)
SNAP Headgear accessories
The only head-gear that is simple to self-apply and guarantees accurate electrode placement. The only pre-saturated snap electrodes for tES in deployed environment.
ElectraRx software
ElectraRx integrates complete screening and assessments, tDCS dose management, and online digital therapeutics all in one place that can be accessed from anywhere.
Learn more...
Clinical Systems
Soterix Medical is committed to provide patients and physicians the most advanced, user-friendly, and effective neuromodulation treatments. Our clinical tDCS platforms are the only system to incorporate the latest, most robust technology. Unique electrode and head-gear snap-in technology make consistent and comfortable stimulation “a snap” for patient and care-givers.
Depression LTE
Pain X
Soterix Medical REMOTE Neuromodulation systems are uniquely validated
Soterix Medical hardware and accessories for remote use is the only equipment designed and validated for the purpose. Other systems designed for use by professional and medical and research centers cannot be rigged for home use.
Soterix Medical REMOTE is supported by over a dozen clinical trials including the demonstration of tolerability, reproducibility, and compliance.
-
Delivering Transcranial Direct Current Stimulation Away From Clinic: Remotely Supervised tDCS. Mil Med. 2020
-
Telerehabilitation benefits patients with multiple sclerosis in an urban setting. J Telemed Telecare. 2019
-
Long term at-home treatment with transcranial direct current stimulation(tDCS) improves symptoms of cerebellar ataxia: a case report. J Neuroeng Rehabil. 2019
-
Introducing the thematic series on transcranial direct current stimulation (tDCS) for motor rehabilitation: on the way to optimal clinical use. J Neuroeng Rehabil. 2019
-
Generalizing remotely supervised tDCS: feasibility and benefit in Parkinson's disease. J Neuroeng Rehabil 2018
-
Remotely-supervised tDCS paired with cognitive training in Parkinson's disease: An open-label study. J Clin Neurosci 2018 Nov
-
Transcranial Direct Current Stimulation Is Feasible for Remotely Supervised Home Delivery in Multiple Sclerosis. Neuromodulation 2016
-
Remotely Supervised tDCS Increases the Benefit of At-Home Cognitive Training in Multiple Sclerosis. Neuromodulation 2018
-
At-Home tDCS With Telehealth Support for Symptom Control in Chronically-Ill Patients With Multiple Symptoms Front Behav Neurosci 2018
-
Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability J Vis Exp. 2017
-
A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation (tDCS) in Multiple Sclerosis (MS). J Vis Exp. 2015
-
Remotely-supervised tDCS for clinical trials: guidelines for technology and protocols. Front Syst Neurosci. 2015